We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiopulmonary Bypass (CPB) Pumps and Blood Activation

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by University Hospital, Angers.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00187967
First Posted: September 16, 2005
Last Update Posted: September 26, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Angers
September 9, 2005
September 16, 2005
September 26, 2007
January 2005
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00187967 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cardiopulmonary Bypass (CPB) Pumps and Blood Activation
Blood Activation During Cardiopulmonary Bypass Using Roller or Centrifugal Pumps
Blood activation induced by cardiopulmonary bypass may compromise the postoperative outcome. The goal of this study is to compare blood activation induced by cardiopulmonary bypass performed with centrifugal pump or roller pump in patients undergoing coronary artery surgery.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
  • Cardiopulmonary Bypass
  • Coronary Artery Disease
Device: pumps used for cardiopulmonary bypass
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Men undergoing coronary artery bypass grafting using cardiopulmonary bypass
  • Aspirin therapy

Exclusion Criteria:

  • Redo surgery
  • Acute coronary syndrome requiring urgent surgery
  • Oral anticoagulant therapy
  • Organ dysfunction or chronic inflammatory disease
  • Surgery other than coronary artery bypass grafting
Sexes Eligible for Study: Male
18 Years and older   (Adult, Senior)
Not Provided
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT00187967
PHRC 03-03
Not Provided
Not Provided
Not Provided
Not Provided
University Hospital, Angers
Not Provided
Principal Investigator: Christophe Baufreton, MD, PhD University Hospital of Angers, France
University Hospital, Angers
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP